Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite.

Lavonas EJ, Kokko J, Schaeffer TH, Mlynarchek SL, Bogdan GM, Dart RC.

Ann Emerg Med. 2011 Feb;57(2):128-137.e3. doi: 10.1016/j.annemergmed.2010.06.550. Epub 2010 Oct 16.

PMID:
20952098
2.

Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review.

Lavonas EJ, Schaeffer TH, Kokko J, Mlynarchek SL, Bogdan GM.

BMC Emerg Med. 2009 Jun 22;9:13. doi: 10.1186/1471-227X-9-13. Review.

3.

Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom.

Cannon R, Ruha AM, Kashani J.

Ann Emerg Med. 2008 Apr;51(4):407-11. doi: 10.1016/j.annemergmed.2007.09.036. Epub 2008 Jan 11.

PMID:
18191286
4.

Crotalidae polyvalent immune Fab for the treatment of pediatric crotaline envenomation.

Goto CS, Feng SY.

Pediatr Emerg Care. 2009 Apr;25(4):273-9; quiz 280-2. doi: 10.1097/PEC.0b013e31819f1f1e. Review.

PMID:
19369845
5.

The use and tolerability of Crotalidae Polyvalent Immune FAB (Ovine) in pediatric envenomations.

Farrar HC, Grayham T, Bolden B, Vyas D, Graham J, James LP.

Clin Pediatr (Phila). 2012 Oct;51(10):945-9. doi: 10.1177/0009922812441660. Epub 2012 Apr 17.

PMID:
22511193
6.

Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite.

Lavonas EJ, Gerardo CJ, O'Malley G, Arnold TC, Bush SP, Banner W Jr, Steffens M, Kerns WP 2nd.

Ann Emerg Med. 2004 Feb;43(2):200-6.

PMID:
14747809
7.

Tracheal intubation prevented with administration of Fab antivenom after severe crotaline envenomation.

Bebarta VS, Ferre RM, Peck M.

J Emerg Med. 2010 Jul;39(1):e81-3. doi: 10.1016/j.jemermed.2007.11.096. Epub 2008 Aug 23.

PMID:
18722730
8.

Crotalidae polyvalent immune Fab (ovine) antivenom is effective in the neutralization of South American viperidae venoms in a murine model.

Richardson WH 3rd, Tanen DA, Tong TC, Betten DP, Carstairs SD, Williams SR, Cantrell FL, Clark RF.

Ann Emerg Med. 2005 Jun;45(6):595-602.

PMID:
15940091
9.

Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation.

Ruha AM, Curry SC, Beuhler M, Katz K, Brooks DE, Graeme KA, Wallace K, Gerkin R, Lovecchio F, Wax P, Selden B.

Ann Emerg Med. 2002 Jun;39(6):609-15.

PMID:
12023703
10.

Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation.

Offerman SR, Bush SP, Moynihan JA, Clark RF.

Pediatrics. 2002 Nov;110(5):968-71.

PMID:
12415038
11.

A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States.

Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, McKinney P, McNally J, Kitchens CS, Curry SC, Bogdan GM, Ward SB, Porter RS.

Arch Intern Med. 2001 Sep 10;161(16):2030-6.

PMID:
11525706
12.

Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri).

Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD.

Ann Emerg Med. 2002 Dec;40(6):619-24.

PMID:
12447339
13.

Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children.

Johnson PN, McGoodwin L, Banner W Jr.

Emerg Med J. 2008 Dec;25(12):793-8. doi: 10.1136/emj.2007.054916. Review.

PMID:
19033492
14.

Crotalidae polyvalent immune Fab: in patients with North American crotaline envenomation.

Keating GM.

BioDrugs. 2011 Apr 1;25(2):69-76. doi: 10.2165/11207250-000000000-00000. Review.

PMID:
21443271
15.

Factors associated with difficulty achieving initial control with crotalidae polyvalent immune fab antivenom in snakebite patients.

Yin S, Kokko J, Lavonas E, Mlynarchek S, Bogdan G, Schaeffer T.

Acad Emerg Med. 2011 Jan;18(1):46-52. doi: 10.1111/j.1553-2712.2010.00958.x. Epub 2010 Dec 16.

16.

Efficacy, safety, and use of snake antivenoms in the United States.

Dart RC, McNally J.

Ann Emerg Med. 2001 Feb;37(2):181-8. Review.

PMID:
11174237
17.

Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom.

Ruha AM, Curry SC, Albrecht C, Riley B, Pizon A.

Toxicon. 2011 Jan;57(1):53-9. doi: 10.1016/j.toxicon.2010.09.014. Epub 2010 Oct 8.

PMID:
20920516
18.

Effectiveness of delayed use of crotalidae polyvalent immune Fab (ovine) antivenom.

Bebarta V, Dart RC.

J Toxicol Clin Toxicol. 2004;42(3):321-4.

PMID:
15362603
19.

Recurrent hemorrhage after western diamondback rattlesnake envenomation treated with crotalidae polyvalent immune fab (ovine).

Fazelat J, Teperman SH, Touger M.

Clin Toxicol (Phila). 2008 Nov;46(9):823-6. doi: 10.1080/15563650701753849.

PMID:
18608290
20.

Recurrent coagulopathy with delayed significant bleeding after crotaline envenomation.

O'Brien NF, DeMott MC, Suchard JR, Clark RF, Peterson BM.

Pediatr Emerg Care. 2009 Jul;25(7):457-9. doi: 10.1097/PEC.0b013e3181ab7871.

PMID:
19606002

Supplemental Content

Support Center